The deficiency of fibrinogen, prothrombin, factor V (FV), FVII, FVIII, FIX, FX, FXI, and FXIII,
called rare coagulation disorders (RCDs), may result in coagulopathies leading to …

Factor XI (FXI) deficiency (hemophilia C or Rosenthal disease) was first described in the
1950s by Rosenthal and colleagues 1 in four generations of a family experiencing bleeding …

Hematologic diseases include a broad range of acquired and congenital disorders, many of
which affect plasma proteins that control hemostasis and immune responses. Therapeutic …

Factor XI (FXI) deficiency is a rare bleeding disorder that presents complex challenges in
patient assessment and bleeding risk management. Despite generally causing mild to …

Anticoagulant therapy is a mainstay in the management of patients with cardiovascular
disease and related conditions characterized by a heightened risk for thrombosis. Acute …

ABSTRACT Introduction Factor XI (FXI) deficiency is associated with highly variable
bleeding, including excessive gynecologic and obstetrical bleeding. Since approximately …

Hemophilia C or factor XI deficiency is a rare clotting disorder with prevalence of only 1 per 1
million. A 24-year-old male with multiple abdominal surgeries complicated by wound …

Background: Different preparations for therapeutic plasma are available on the market. The
German hemotherapy guideline has been completely updated in 2020 and, for this purpose …

Introduction Cardiovascular events in patients with inherited bleeding disorders are
challenging to manage. The risk of bleeding secondary to antithrombotic treatment must be …

Abstract Purpose of Review Management of coagulation in pregnancy requires a
multidisciplinary and dynamic approach by obstetric anesthesiologists, obstetricians, and …